Could a diabetes drug protect obese Teens' hearts?
Disease control
Recruiting now
This study tests whether semaglutide, a drug used for weight loss, can reduce markers of heart disease risk in adolescents aged 12 to 15 with severe obesity (class 2 or 3). Participants receive semaglutide and undergo heart scans, body composition tests, and blood work over about…
Sponsor: John Bauer • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC